Avapritinib, Avapritinib
BLU-285-2404
Approved small_molecule active
Quick answer
Avapritinib, Avapritinib for Systemic Mastocytosis is a Approved program (small_molecule) at Blueprint Medicines (Netherlands) B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Blueprint Medicines (Netherlands) B.V.
- Indication
- Systemic Mastocytosis
- Phase
- Approved
- Modality
- small_molecule
- Status
- active